@ARTICLE{10.3389/fpsyt.2013.00185, AUTHOR={Marhe, Reshmi and Franken, Ingmar and Luijten, Maartje}, TITLE={The Clinical Relevance of Neurocognitive Measures in Addiction}, JOURNAL={Frontiers in Psychiatry}, VOLUME={4}, YEAR={2014}, URL={https://www.frontiersin.org/articles/10.3389/fpsyt.2013.00185}, DOI={10.3389/fpsyt.2013.00185}, ISSN={1664-0640}, ABSTRACT={One of the major challenges in addiction treatment is relapse prevention, as rates of relapse following treatment remain very high across the main classes of drugs of abuse. Relapse prevention could be improved by a better understanding of the factors that influence treatment outcomes, including better predictors of risk of relapse following treatment. Recent developments in cognitive neuroscience point to neurocognitive measures (i.e., brain-imaging measures during cognitive-task performance) as potential predictors of relapse. These might even be better predictors than self-report measures, such as craving. We first give an overview of the current state of the field, and then discuss the outstanding challenges and future directions in this area of research.} }